Global Human Granulocyte Colony-stimulating Factor Market Growth (Status and Outlook) 2024-2031

Report ID: 1394784 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Human Granulocyte Colony-stimulating Factor by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Human Granulocyte Colony-stimulating Factor by Country/Region, 2017, 2022 & 2028
    2.2 Human Granulocyte Colony-stimulating Factor Segment by Type
        2.2.1 300μg/Dose
        2.2.2 150μg/Dose
        2.2.3 75μg/Dose
        2.2.4 Others
    2.3 Human Granulocyte Colony-stimulating Factor Sales by Type
        2.3.1 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
        2.3.2 Global Human Granulocyte Colony-stimulating Factor Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Type (2017-2022)
    2.4 Human Granulocyte Colony-stimulating Factor Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
    2.5 Human Granulocyte Colony-stimulating Factor Sales by Application
        2.5.1 Global Human Granulocyte Colony-stimulating Factor Sale Market Share by Application (2017-2022)
        2.5.2 Global Human Granulocyte Colony-stimulating Factor Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Application (2017-2022)
3 Global Human Granulocyte Colony-stimulating Factor by Company
    3.1 Global Human Granulocyte Colony-stimulating Factor Breakdown Data by Company
        3.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Company (2020-2022)
        3.1.2 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2020-2022)
    3.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Company (2020-2022)
        3.2.1 Global Human Granulocyte Colony-stimulating Factor Revenue by Company (2020-2022)
        3.2.2 Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2020-2022)
    3.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Company
    3.4 Key Manufacturers Human Granulocyte Colony-stimulating Factor Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Human Granulocyte Colony-stimulating Factor Product Location Distribution
        3.4.2 Players Human Granulocyte Colony-stimulating Factor Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Granulocyte Colony-stimulating Factor by Geographic Region
    4.1 World Historic Human Granulocyte Colony-stimulating Factor Market Size by Geographic Region (2017-2022)
        4.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Geographic Region
    4.2 World Historic Human Granulocyte Colony-stimulating Factor Market Size by Country/Region (2017-2022)
        4.2.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Country/Region
    4.3 Americas Human Granulocyte Colony-stimulating Factor Sales Growth
    4.4 APAC Human Granulocyte Colony-stimulating Factor Sales Growth
    4.5 Europe Human Granulocyte Colony-stimulating Factor Sales Growth
    4.6 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Growth
5 Americas
    5.1 Americas Human Granulocyte Colony-stimulating Factor Sales by Country
        5.1.1 Americas Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)
        5.1.2 Americas Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)
    5.2 Americas Human Granulocyte Colony-stimulating Factor Sales by Type
    5.3 Americas Human Granulocyte Colony-stimulating Factor Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Human Granulocyte Colony-stimulating Factor Sales by Region
        6.1.1 APAC Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022)
        6.1.2 APAC Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022)
    6.2 APAC Human Granulocyte Colony-stimulating Factor Sales by Type
    6.3 APAC Human Granulocyte Colony-stimulating Factor Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Human Granulocyte Colony-stimulating Factor by Country
        7.1.1 Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)
        7.1.2 Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)
    7.2 Europe Human Granulocyte Colony-stimulating Factor Sales by Type
    7.3 Europe Human Granulocyte Colony-stimulating Factor Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor by Country
        8.1.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)
    8.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type
    8.3 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Human Granulocyte Colony-stimulating Factor
    10.3 Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor
    10.4 Industry Chain Structure of Human Granulocyte Colony-stimulating Factor
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Human Granulocyte Colony-stimulating Factor Distributors
    11.3 Human Granulocyte Colony-stimulating Factor Customer
12 World Forecast Review for Human Granulocyte Colony-stimulating Factor by Geographic Region
    12.1 Global Human Granulocyte Colony-stimulating Factor Market Size Forecast by Region
        12.1.1 Global Human Granulocyte Colony-stimulating Factor Forecast by Region (2023-2028)
        12.1.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Human Granulocyte Colony-stimulating Factor Forecast by Type
    12.7 Global Human Granulocyte Colony-stimulating Factor Forecast by Application
13 Key Players Analysis
    13.1 Chugai Pharmaceutical
        13.1.1 Chugai Pharmaceutical Company Information
        13.1.2 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.1.3 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Chugai Pharmaceutical Main Business Overview
        13.1.5 Chugai Pharmaceutical Latest Developments
    13.2 Kyowa Hakko Kirin
        13.2.1 Kyowa Hakko Kirin Company Information
        13.2.2 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product Offered
        13.2.3 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Kyowa Hakko Kirin Main Business Overview
        13.2.5 Kyowa Hakko Kirin Latest Developments
    13.3 Sanway
        13.3.1 Sanway Company Information
        13.3.2 Sanway Human Granulocyte Colony-stimulating Factor Product Offered
        13.3.3 Sanway Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Sanway Main Business Overview
        13.3.5 Sanway Latest Developments
    13.4 GenSci
        13.4.1 GenSci Company Information
        13.4.2 GenSci Human Granulocyte Colony-stimulating Factor Product Offered
        13.4.3 GenSci Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 GenSci Main Business Overview
        13.4.5 GenSci Latest Developments
    13.5 SL PHARM
        13.5.1 SL PHARM Company Information
        13.5.2 SL PHARM Human Granulocyte Colony-stimulating Factor Product Offered
        13.5.3 SL PHARM Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 SL PHARM Main Business Overview
        13.5.5 SL PHARM Latest Developments
    13.6 Kexing Bioproducts
        13.6.1 Kexing Bioproducts Company Information
        13.6.2 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product Offered
        13.6.3 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Kexing Bioproducts Main Business Overview
        13.6.5 Kexing Bioproducts Latest Developments
    13.7 Qilu Pharmaceutical
        13.7.1 Qilu Pharmaceutical Company Information
        13.7.2 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.7.3 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Qilu Pharmaceutical Main Business Overview
        13.7.5 Qilu Pharmaceutical Latest Developments
    13.8 CSPC
        13.8.1 CSPC Company Information
        13.8.2 CSPC Human Granulocyte Colony-stimulating Factor Product Offered
        13.8.3 CSPC Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 CSPC Main Business Overview
        13.8.5 CSPC Latest Developments
    13.9 Wuzhong Pharmaceutical
        13.9.1 Wuzhong Pharmaceutical Company Information
        13.9.2 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.9.3 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Wuzhong Pharmaceutical Main Business Overview
        13.9.5 Wuzhong Pharmaceutical Latest Developments
    13.10 Quangang Pharmaceutical
        13.10.1 Quangang Pharmaceutical Company Information
        13.10.2 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.10.3 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Quangang Pharmaceutical Main Business Overview
        13.10.5 Quangang Pharmaceutical Latest Developments
    13.11 Huabei Pharmaceutical
        13.11.1 Huabei Pharmaceutical Company Information
        13.11.2 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.11.3 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Huabei Pharmaceutical Main Business Overview
        13.11.5 Huabei Pharmaceutical Latest Developments
    13.12 Harbin Pharmaceutical
        13.12.1 Harbin Pharmaceutical Company Information
        13.12.2 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.12.3 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Harbin Pharmaceutical Main Business Overview
        13.12.5 Harbin Pharmaceutical Latest Developments
    13.13 Amoytop Biotech
        13.13.1 Amoytop Biotech Company Information
        13.13.2 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product Offered
        13.13.3 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Amoytop Biotech Main Business Overview
        13.13.5 Amoytop Biotech Latest Developments
    13.14 Jiuyuan Gene Engineering
        13.14.1 Jiuyuan Gene Engineering Company Information
        13.14.2 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product Offered
        13.14.3 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Jiuyuan Gene Engineering Main Business Overview
        13.14.5 Jiuyuan Gene Engineering Latest Developments
    13.15 Four Rings Biopharmaceutical
        13.15.1 Four Rings Biopharmaceutical Company Information
        13.15.2 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
        13.15.3 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Four Rings Biopharmaceutical Main Business Overview
        13.15.5 Four Rings Biopharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Human Granulocyte Colony-stimulating Factor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Human Granulocyte Colony-stimulating Factor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 300μg/Dose
    Table 4. Major Players of 150μg/Dose
    Table 5. Major Players of 75μg/Dose
    Table 6. Major Players of Others
    Table 7. Global Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
    Table 8. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
    Table 9. Global Human Granulocyte Colony-stimulating Factor Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2017-2022)
    Table 11. Global Human Granulocyte Colony-stimulating Factor Sale Price by Type (2017-2022) & (US$/Unit)
    Table 12. Global Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
    Table 13. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Table 14. Global Human Granulocyte Colony-stimulating Factor Revenue by Application (2017-2022)
    Table 15. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application (2017-2022)
    Table 16. Global Human Granulocyte Colony-stimulating Factor Sale Price by Application (2017-2022) & (US$/Unit)
    Table 17. Global Human Granulocyte Colony-stimulating Factor Sales by Company (2020-2022) & (K Units)
    Table 18. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2020-2022)
    Table 19. Global Human Granulocyte Colony-stimulating Factor Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2020-2022)
    Table 21. Global Human Granulocyte Colony-stimulating Factor Sale Price by Company (2020-2022) & (US$/Unit)
    Table 22. Key Manufacturers Human Granulocyte Colony-stimulating Factor Producing Area Distribution and Sales Area
    Table 23. Players Human Granulocyte Colony-stimulating Factor Products Offered
    Table 24. Human Granulocyte Colony-stimulating Factor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Human Granulocyte Colony-stimulating Factor Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Human Granulocyte Colony-stimulating Factor Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Human Granulocyte Colony-stimulating Factor Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Human Granulocyte Colony-stimulating Factor Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)
    Table 37. Americas Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 39. Americas Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
    Table 41. Americas Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
    Table 42. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Table 43. APAC Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2022)
    Table 45. APAC Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2017-2022)
    Table 47. APAC Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
    Table 49. APAC Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
    Table 50. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Table 51. Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)
    Table 53. Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 55. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
    Table 57. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
    Table 58. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)
    Table 66. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Human Granulocyte Colony-stimulating Factor
    Table 68. Key Market Challenges & Risks of Human Granulocyte Colony-stimulating Factor
    Table 69. Key Industry Trends of Human Granulocyte Colony-stimulating Factor
    Table 70. Human Granulocyte Colony-stimulating Factor Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Human Granulocyte Colony-stimulating Factor Distributors List
    Table 73. Human Granulocyte Colony-stimulating Factor Customer List
    Table 74. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Human Granulocyte Colony-stimulating Factor Sales Market Forecast by Region
    Table 76. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Human Granulocyte Colony-stimulating Factor Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Human Granulocyte Colony-stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Chugai Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 95. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 96. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 97. Chugai Pharmaceutical Main Business
    Table 98. Chugai Pharmaceutical Latest Developments
    Table 99. Kyowa Hakko Kirin Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 100. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product Offered
    Table 101. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 102. Kyowa Hakko Kirin Main Business
    Table 103. Kyowa Hakko Kirin Latest Developments
    Table 104. Sanway Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 105. Sanway Human Granulocyte Colony-stimulating Factor Product Offered
    Table 106. Sanway Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 107. Sanway Main Business
    Table 108. Sanway Latest Developments
    Table 109. GenSci Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 110. GenSci Human Granulocyte Colony-stimulating Factor Product Offered
    Table 111. GenSci Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 112. GenSci Main Business
    Table 113. GenSci Latest Developments
    Table 114. SL PHARM Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 115. SL PHARM Human Granulocyte Colony-stimulating Factor Product Offered
    Table 116. SL PHARM Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 117. SL PHARM Main Business
    Table 118. SL PHARM Latest Developments
    Table 119. Kexing Bioproducts Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 120. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product Offered
    Table 121. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 122. Kexing Bioproducts Main Business
    Table 123. Kexing Bioproducts Latest Developments
    Table 124. Qilu Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 125. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 126. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 127. Qilu Pharmaceutical Main Business
    Table 128. Qilu Pharmaceutical Latest Developments
    Table 129. CSPC Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 130. CSPC Human Granulocyte Colony-stimulating Factor Product Offered
    Table 131. CSPC Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 132. CSPC Main Business
    Table 133. CSPC Latest Developments
    Table 134. Wuzhong Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 135. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 136. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 137. Wuzhong Pharmaceutical Main Business
    Table 138. Wuzhong Pharmaceutical Latest Developments
    Table 139. Quangang Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 140. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 141. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 142. Quangang Pharmaceutical Main Business
    Table 143. Quangang Pharmaceutical Latest Developments
    Table 144. Huabei Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 145. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 146. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 147. Huabei Pharmaceutical Main Business
    Table 148. Huabei Pharmaceutical Latest Developments
    Table 149. Harbin Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 150. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 151. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 152. Harbin Pharmaceutical Main Business
    Table 153. Harbin Pharmaceutical Latest Developments
    Table 154. Amoytop Biotech Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 155. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product Offered
    Table 156. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 157. Amoytop Biotech Main Business
    Table 158. Amoytop Biotech Latest Developments
    Table 159. Jiuyuan Gene Engineering Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 160. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product Offered
    Table 161. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 162. Jiuyuan Gene Engineering Main Business
    Table 163. Jiuyuan Gene Engineering Latest Developments
    Table 164. Four Rings Biopharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors
    Table 165. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered
    Table 166. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 167. Four Rings Biopharmaceutical Main Business
    Table 168. Four Rings Biopharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Human Granulocyte Colony-stimulating Factor
    Figure 2. Human Granulocyte Colony-stimulating Factor Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Human Granulocyte Colony-stimulating Factor Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Human Granulocyte Colony-stimulating Factor Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Human Granulocyte Colony-stimulating Factor Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 300μg/Dose
    Figure 10. Product Picture of 150μg/Dose
    Figure 11. Product Picture of 75μg/Dose
    Figure 12. Product Picture of Others
    Figure 13. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2021
    Figure 14. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2017-2022)
    Figure 15. Human Granulocyte Colony-stimulating Factor Consumed in Hospital
    Figure 16. Global Human Granulocyte Colony-stimulating Factor Market: Hospital (2017-2022) & (K Units)
    Figure 17. Human Granulocyte Colony-stimulating Factor Consumed in Clinic
    Figure 18. Global Human Granulocyte Colony-stimulating Factor Market: Clinic (2017-2022) & (K Units)
    Figure 19. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)
    Figure 20. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application in 2021
    Figure 21. Human Granulocyte Colony-stimulating Factor Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company in 2021
    Figure 23. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2022)
    Figure 26. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)
    Figure 28. Americas Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)
    Figure 30. APAC Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)
    Figure 32. Europe Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021
    Figure 36. Americas Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021
    Figure 37. United States Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Region in 2021
    Figure 42. APAC Human Granulocyte Colony-stimulating Factor Revenue Market Share by Regions in 2021
    Figure 43. China Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021
    Figure 50. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021
    Figure 51. Germany Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021
    Figure 58. Egypt Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Human Granulocyte Colony-stimulating Factor in 2021
    Figure 64. Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor
    Figure 65. Industry Chain Structure of Human Granulocyte Colony-stimulating Factor
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Human Granulocyte Colony-stimulating Factor Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Human Granulocyte Colony-stimulating Factor Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Human Granulocyte Colony-stimulating Factor Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports